| |
| |
|
| Insider
Information: |
Gage L Patrick |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
123,884 |
|
|
Indirect Shares
|
1,850 |
|
|
| Direct
Value |
$1,992,457 |
|
|
|
Indirect Value
|
$111,925 |
|
|
| Total
Shares |
125,734 |
|
|
| Total
Value |
$2,104,382 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 184.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
Interim CEO, Director |
2008-04-28 |
19,555 |
2004-05-24 |
0 |
Premium* |
|
|
Neose Technologies Inc |
NTEC |
Director |
2009-01-27 |
75,397 |
2005-05-05 |
0 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
Director |
2021-11-08 |
28,932 |
2021-11-08 |
1,850 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2004-05-24 |
4 |
B |
$19.00 |
$38,078 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2005-05-05 |
4 |
B |
$18.04 |
$100,242 |
D/D |
5,555 |
7,555 |
2.39 |
- |
|
| NTEC |
Neose Technologies Inc |
Director |
– • – |
2005-05-05 |
4 |
B |
$2.78 |
$25,573 |
D/D |
9,200 |
12,700 |
2.39 |
- |
|
| NTEC |
Neose Technologies Inc |
Director |
– • – |
2007-03-26 |
4 |
B |
$2.00 |
$30,336 |
D/D |
15,000 |
27,700 |
2.39 |
- |
|
| NTEC |
Neose Technologies Inc |
Director |
– • – |
2007-06-07 |
4 |
B |
$2.59 |
$36,001 |
D/D |
13,900 |
41,600 |
2.39 |
- |
|
| NTEC |
Neose Technologies Inc |
Director |
– • – |
2007-06-08 |
4 |
B |
$2.60 |
$39,130 |
D/D |
15,050 |
56,650 |
2.39 |
- |
|
| NTEC |
Neose Technologies Inc |
Director |
– • – |
2007-06-11 |
4 |
B |
$2.60 |
$27,430 |
D/D |
10,550 |
67,200 |
2.39 |
- |
|
| NTEC |
Neose Technologies Inc |
Director |
– • – |
2009-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,197 |
75,397 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2014-05-09 |
4 |
B |
$4.09 |
$40,892 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2014-05-09 |
4 |
B |
$4.10 |
$3,485 |
I/I |
850 |
850 |
2.1 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-05-14 |
4 |
B |
$9.25 |
$46,249 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-05-28 |
4 |
B |
$10.70 |
$9,095 |
I/I |
850 |
850 |
2.1 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-06-04 |
4 |
B |
$10.05 |
$5,025 |
I/I |
500 |
1,350 |
2.1 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-06-05 |
4 |
B |
$10.28 |
$10,027 |
I/I |
975 |
2,325 |
2.1 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-06-13 |
4 |
B |
$11.42 |
$5,710 |
I/I |
500 |
2,825 |
2.1 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2015-05-06 |
4 |
B |
$5.69 |
$57,124 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2015-08-12 |
4 |
S |
$45.00 |
$675,000 |
D/D |
(15,000) |
5,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2015-08-12 |
4 |
OE |
$7.07 |
$106,050 |
D/D |
15,000 |
20,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2015-08-20 |
4 |
B |
$6.46 |
$65,489 |
D/D |
10,000 |
30,000 |
2.39 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2015-08-31 |
4 |
B |
$6.95 |
$6,950 |
I/I |
1,000 |
1,850 |
2.1 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2015-10-02 |
4 |
OE |
$2.03 |
$40,600 |
D/D |
20,000 |
25,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2017-03-15 |
4 |
B |
$7.49 |
$74,900 |
D/D |
10,000 |
35,000 |
2.39 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2017-03-15 |
4 |
B |
$7.47 |
$7,470 |
I/I |
1,000 |
3,825 |
2.1 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-08-29 |
4 |
AS |
$14.00 |
$70,000 |
D/D |
(5,000) |
30,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-08-29 |
4 |
OE |
$4.02 |
$20,100 |
D/D |
5,000 |
35,000 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
